Clinical Trials Logo

Filter by:
NCT ID: NCT05906108 Active, not recruiting - Internet Addiction Clinical Trials

WeChat-based Intervention for Internet Addiction

Start date: March 10, 2023
Phase: N/A
Study type: Interventional

The study aims to design an integrated model which combined self-initiated online learning and personalized interactive behavioral support delivered via WeChat for university students to reduce internet addiction level.

NCT ID: NCT05904054 Active, not recruiting - COVID-19 Clinical Trials

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

Start date: June 15, 2023
Phase: Phase 2
Study type: Interventional

This is an open-labeled, no placebo, Phase IIa clinical trial. The purpose of this study is to evaluate the immunogenicity and safety of one booster vaccine dose of SARS-CoV-2 DNA Vaccine (ICCOV) in adults aged 18 to 75 years who have received two to four dosese of COVID-19 vaccine.

NCT ID: NCT05832346 Active, not recruiting - Clinical trials for Psychosocial Problem

Effects of a Laughter Yoga Program in Adolescents With Disabilities

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

A pilot randomized controlled trial will be adopted. A total of forty adolescents with intellectual and physical disabilities will be randomly allocated into either intervention group receiving a 4-week laughter yoga programme (8 sessions) or control group receiving routine care in a 1:1 ratio based on computer-generated random schedule. The aim of this pilot study is to preliminarily evaluate the effects of a 4-week laughter yoga programme (8 sessions) on the mood, anxiety and loneliness among adolescents with intellectual and physical disabilities in a special school in Hong Kong. Hypotheses for primary outcomes of this study are as follows: H.1 Participants receiving the 4-week laughter yoga programme (8 sessions) (intervention group) will have a greater improvement on mood level than the participants receiving routine care provided by the special school as usual (control group). H.2 Participants receiving the 4-week laughter yoga programme (8 sessions) (intervention group) will have a greater reduction on anxiety than the participants receiving routine care provided by the special school as usual (control group). H.3 Participants receiving the 4-week laughter yoga programme (8 sessions) (intervention group) will have a greater reduction on loneliness than the participants receiving routine care provided by the special school as usual (control group).

NCT ID: NCT05811169 Active, not recruiting - Clinical trials for Non-small Cell Lung Cancer

Quest for Tumour Evolution of Non-small Cell Lung Cancer

Start date: February 15, 2023
Phase:
Study type: Observational

To study and comprehend the evolutionary and genomic landscape between primary and metastatic sites and the dynamics of intratumour and intertumour heterogeneity over time with reference to the treatment modalities for each Chinese patient with non-small cell lung cancer.

NCT ID: NCT05809934 Active, not recruiting - Clinical trials for Nonalcoholic Steatohepatitis

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

FORTUNA
Start date: March 15, 2023
Phase: Phase 2
Study type: Interventional

A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis and who are carriers of the PNPLA3 148M Risk Allele

NCT ID: NCT05785286 Active, not recruiting - Clinical trials for Benign Prostatic Hyperplasia (BPH)

To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire

Start date: February 27, 2023
Phase:
Study type: Observational

This study is to linguistically and psychometrically validate the translated and culturally adapted Hong Kong Chinese version of the BPH 3-item questionnaire.

NCT ID: NCT05782465 Active, not recruiting - Stomach Neoplasm Clinical Trials

Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)

Start date: August 23, 2019
Phase:
Study type: Observational

This study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in the molecular-test-positive group will be significantly higher than that in the molecular-test-negative group. Such a test has the potential to guide clinicians to better manage patients with IM by allowing endoscopic surveillance to be focused on individuals at very-high-risk of developing stomach cancer, at the same time avoiding or reducing endoscopies for those at lower risk.

NCT ID: NCT05767788 Active, not recruiting - Knee Osteoarthritis Clinical Trials

Mobilization With Movement (MWM) on Knee Osteoarthritis (OA)

Start date: December 10, 2022
Phase: N/A
Study type: Interventional

Movement with mobilization (MWM) is an effective manual therapy to improve pain and function of patients with knee osteoarthritis (OA). However, immediate, and prolonged effects after prolonged MWM period was under-investigated. In this double-blinded randomized control trial, 40 patients are needed. The subjects and assessors will be blinded. Subjects in intervention group will receive MWM twice a week and corresponding home exercise for 6 weeks. Participants in control group will only receive sham treatment with light touch. The effects on knee pain in visual analogue scale (VAS); flexion and extension range of motion (ROM) by goniometer; strength by hand-held dynamometer; function by Timed Up and Go Test (TUG) and 30-second Chair Stand Test; and health-related quality of life (HRQoL) by Knee Injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) just after, 1-month and 3-month after treatment will be compared with baseline. Six-month after treatment, KOOS and WOMAC will be conducted.

NCT ID: NCT05758272 Active, not recruiting - Exercise Clinical Trials

Evaluation of a Workplace Smoking Cessation Program in Hong Kong (Phase VI)

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study aims to test, by a 2-arm RCT, the effectiveness of an intervention that includes mobile phone-supported simple physical exercise for smoking cessation in workplaces in Hong Kong.

NCT ID: NCT05732220 Active, not recruiting - Smoking Cessation Clinical Trials

Mobile EMA-based Peer Counselling for Youth Smokers

Start date: May 18, 2023
Phase: N/A
Study type: Interventional

This pilot trial aims to examine the feasibility, acceptability, and preliminary effectiveness of EMA-based peer counseling for youth smokers.